Exact Mass: 411.1658

Exact Mass Matches: 411.1658

Found 432 metabolites which its exact mass value is equals to given mass value 411.1658, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

Fluvastatin

(3S,5R,6E)-7-[3-(4-fluorophenyl)-1-(propan-2-yl)-1H-indol-2-yl]-3,5-dihydroxyhept-6-enoic acid

C24H26FNO4 (411.1846)

Fluvastatin is an antilipemic agent that competitively inhibits hydroxymethylglutaryl-coenzyme A (HMG-CoA) reductase. HMG-CoA reducuase catalyzes the conversion of HMG-CoA to mevalonic acid, the rate-limiting step in cholesterol biosynthesis. Fluvastatin belongs to a class of medications called statins and is used to reduce plasma cholesterol levels and prevent cardiovascular disease. C78276 - Agent Affecting Digestive System or Metabolism > C29703 - Antilipidemic Agent C471 - Enzyme Inhibitor > C1655 - HMG-CoA Reductase Inhibitor Fluvastatin (XU 62-320 free acid) is a first fully synthetic, competitive HMG-CoA reductase inhibitor with an IC50 of 8 nM. Fluvastatin protects vascular smooth muscle cells against oxidative stress through the Nrf2-dependent antioxidant pathway[1][2][3].

Mandipropamid

Pesticide4_Mandipropamid_C23H22ClNO4_2-(4-Chlorophenyl)-N-{2-[3-methoxy-4-(2-propyn-1-yloxy)phenyl]ethyl}-2-(2-propyn-1-yloxy)acetamide

C23H22ClNO4 (411.1237)

D016573 - Agrochemicals D010575 - Pesticides CONFIDENCE standard compound; EAWAG_UCHEM_ID 3061

Acetophenazine

1-(10-{3-[4-(2-hydroxyethyl)piperazin-1-yl]propyl}-10H-phenothiazin-2-yl)ethan-1-one

C23H29N3O2S (411.198)

Acetophenazine is only found in individuals that have used or taken this drug.It is an antipsychotic drug of moderate-potency. It is used in the treatment of disorganized and psychotic thinking. It is also used to help treat false perceptions (e.g. hallucinations or delusions).Acetophenazine blocks postsynaptic mesolimbic dopaminergic D1 and D2 receptors in the brain; depresses the release of hypothalamic and hypophyseal hormones and is believed to depress the reticular activating system thus affecting basal metabolism, body temperature, wakefulness, vasomotor tone, and emesis. N - Nervous system > N05 - Psycholeptics > N05A - Antipsychotics > N05AB - Phenothiazines with piperazine structure C78272 - Agent Affecting Nervous System > C29710 - Antipsychotic Agent

Altanserin

3-{2-[4-(4-fluorobenzoyl)piperidin-1-yl]ethyl}-2-sulfanylidene-1,2,3,4-tetrahydroquinazolin-4-one

C22H22FN3O2S (411.1417)

D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D012702 - Serotonin Antagonists C78272 - Agent Affecting Nervous System > C66885 - Serotonin Antagonist Altanserin can synthesize Fluorine-18 Altanserin. Fluorine-18 Altanserin binds to the brain 5HT2 receptors[1].

COELENTERAMIDE

Oxidized Oplophorus luciferin

C25H21N3O3 (411.1583)

Ro 18-5364

5,7-Dihydro-2-(((4-methoxy-3-methyl-2-pyridyl)methyl)sulfinyl)-5,5,7,7-tetramethylindeno(5,6-d)imidazol-6(1H)-one

C22H25N3O3S (411.1617)

Dihydroxyfumitremorgin C

1,2-dihydroxy-7-methoxy-12-(2-methylprop-1-en-1-yl)-10,13,19-triazapentacyclo[11.7.0.0³,¹¹.0⁴,⁹.0¹⁵,¹⁹]icosa-3(11),4(9),5,7-tetraene-14,20-dione

C22H25N3O5 (411.1794)

Dihydroxyfumitremorgin C is from Aspergillus fumigatus. From Aspergillus fumigatus

Ipratropium bromide

C20H30BrNO3 (411.1409)

R - Respiratory system > R03 - Drugs for obstructive airway diseases > R03B - Other drugs for obstructive airway diseases, inhalants > R03BB - Anticholinergics R - Respiratory system > R01 - Nasal preparations > R01A - Decongestants and other nasal preparations for topical use C78272 - Agent Affecting Nervous System > C66880 - Anticholinergic Agent > C29704 - Antimuscarinic Agent D019141 - Respiratory System Agents > D018927 - Anti-Asthmatic Agents > D001993 - Bronchodilator Agents D018377 - Neurotransmitter Agents > D018678 - Cholinergic Agents > D018680 - Cholinergic Antagonists C78273 - Agent Affecting Respiratory System > C29712 - Anti-asthmatic Agent > C319 - Bronchodilator D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents Ipratropium bromide (Sch 1000) is a muscarinic receptor antagonist, with IC50s of 2.9 nM, 2 nM, and 1.7 nM for M1, M2, and M3 receptors, respectively. Ipratropium bromide relaxes smooth muscle, can be used in the research for COPD (chronic obstructive pulmonary disease) and asthma[1][2][3][4][5].

7-Formyldehydrothalicsimidine

4,5,14,15,16-pentamethoxy-10-methyl-10-azatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-1(16),2(7),3,5,8,13(17),14-heptaene-8-carbaldehyde

C23H25NO6 (411.1682)

7-Formyldehydrothalicsimidine is found in beverages. 7-Formyldehydrothalicsimidine is an alkaloid from Annona purpurea (soncoya). Alkaloid from Annona purpurea (soncoya). 7-Formyldehydrothalicsimidine is found in beverages and fruits.

Carphenazine

1-(10-{2-[4-(2-hydroxyethyl)piperazin-1-yl]ethyl}-10H-phenothiazin-2-yl)propan-1-one

C23H29N3O2S (411.198)

Carphenazine is only found in individuals that have used or taken this drug. It is an antipsychotic drug, used in hospitalized patients in the management of chronic schizophrenic psychoses.A yellow, powdered, phenothiazine antipsychotic agent used in the treatment of acute or chronic schizophrenia. The term "phenothiazines" is used to describe the largest of the five main classes of neuroleptic antipsychotic drugs. These drugs have antipsychotic and, often, antiemetic properties, although they may also cause severe side effects such as akathisia, tardive dyskinesia and extrapyramidal symptoms. Carphenazine blocks postsynaptic mesolimbic dopaminergic D1 and D2 receptors in the brain; depresses the release of hypothalamic and hypophyseal hormones and is believed to depress the reticular activating system thus affecting basal metabolism, body temperature, wakefulness, vasomotor tone, and emesis.

Tasosartan

2,4-dimethyl-8-({4-[2-(2H-1,2,3,4-tetrazol-5-yl)phenyl]phenyl}methyl)-5H,6H,7H,8H-pyrido[2,3-d]pyrimidin-7-one

C23H21N7O (411.1807)

Tasosartan is only found in individuals that have used or taken this drug. It is a long-acting angiotensin II (AngII) receptor blocker. Its long duration of action has been attributed to its active metabolite enoltasosartan. It is used to treat patients with essential hypertensionTasosartan is a selective, potent, orally active and long-acting nonpeptide Angiotensin II type 1 (AT1) receptor antagonist. Tasosartan blocks the renin-angiotensin-aldosterone system (RAAS) at the level of the AT1 receptor that mediates most, if not all, of the important actions of Ang II. Tasosartan binds reversibly to the AT1 receptors in vascular smooth muscle and the adrenal gland. As angiotensin II is a vasoconstrictor, which also stimulates the synthesis and release of aldosterone, blockage of its effects results in decreases in systemic vascular resistance. AT1 receptor antagonists avoid the nonspecificity of the Ang I converting enzyme (ACE) inhibitors. C - Cardiovascular system > C09 - Agents acting on the renin-angiotensin system > C09C - Angiotensin ii receptor blockers (arbs), plain > C09CA - Angiotensin ii receptor blockers (arbs), plain C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent > C66930 - Angiotensin II Receptor Antagonist D057911 - Angiotensin Receptor Antagonists > D047228 - Angiotensin II Type 1 Receptor Blockers Tasosartan is a long-acting angiotensin II (AngII) receptor antagonist.

N6-carbamoylthreonyladenosine

(2S,3R)-N-{9-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-9H-purin-6-yl}-3-hydroxy-2-[(C-hydroxycarbonimidoyl)amino]butanimidate

C15H21N7O7 (411.1502)

N6-Carbamoyl-L-threonyladenosine is a member of the class of compounds known as purine nucleosides. Purine nucleosides are compounds composed of a purine base attached to a ribosyl or deoxyribosyl moiety. N6-Carbamoyl-L-threonyladenosine is slightly soluble (in water) and a very weakly acidic compound (based on its pKa). Within the cell, N6-carbamoyl-L-threonyladenosine is primarily located in the cytoplasm. It can also be found in the extracellular space. N6-Carbamoyl-L-threonyladenosine is a minor constituent found in human and bovine milk (PMID: 7702711). Minor constituant found in human, bovine, and goat milk

1,2-Dihexanoyl-sn-glycero-3-phosphoethanolamine

(2-aminoethoxy)[2,3-bis(hexanoyloxy)propoxy]phosphinic acid

C17H34NO8P (411.2022)

Magon

N-(2,4-dimethylphenyl)-3-hydroxy-4-[2-(2-hydroxyphenyl)diazen-1-yl]naphthalene-2-carboxamide

C25H21N3O3 (411.1583)

Cetocycline

3-acetyl-1-amino-4,4a,6,7-tetrahydroxy-8,11-dimethyl-1,2,4a,5,12,12a-hexahydrotetracene-2,5-dione

C22H21NO7 (411.1318)

(3S,5R)-7-[3-(4-Fluorophenyl)-1-propan-2-yl-2-indolyl]-3,5-dihydroxy-6-heptenoic acid

C24H26FNO4 (411.1846)

Entospletinib

6-(2H-indazol-6-yl)-N-[4-(morpholin-4-yl)phenyl]-7H,8H-imidazo[1,2-a]pyrazin-8-imine

C23H21N7O (411.1807)

C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor

2-Amino-1-[2-(4-fluorophenyl)-3-[(4-fluorophenyl)amino]-5,6-dihydro-8,8-dimethylimidazo[1,2-a]pyrazin-7(8H)-yl]ethanone

2-amino-1-[2-(4-fluorophenyl)-3-[(4-fluorophenyl)amino]-8,8-dimethyl-5H,6H,7H,8H-imidazo[1,2-a]pyrazin-7-yl]ethan-1-one

C22H23F2N5O (411.1871)

C254 - Anti-Infective Agent > C276 - Antiparasitic Agent > C277 - Antiprotozoal Agent

Piroxantrone

10-[(3-aminopropyl)imino]-6,8-dihydroxy-14-{2-[(2-hydroxyethyl)amino]ethyl}-14,15-diazatetracyclo[7.6.1.0^{2,7}.0^{13,16}]hexadeca-1,4,6,8,11,13(16)-hexaen-3-one

C21H25N5O4 (411.1906)

C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C2842 - DNA Binding Agent D000970 - Antineoplastic Agents

PKCbeta Inhibitor

3-{1-[3-(1H-imidazol-1-yl)propyl]-1H-indol-3-yl}-4-(phenylamino)-2,5-dihydro-1H-pyrrole-2,5-dione

C24H21N5O2 (411.1695)

Sacubitril

3-[(1-{[1,1-biphenyl]-4-yl}-5-ethoxy-4-methyl-5-oxopentan-2-yl)-C-hydroxycarbonimidoyl]propanoate

C24H29NO5 (411.2046)

N-(2(S)-(Acetylthiomethyl)-3-(2-methylphenyl)-1-oxopropyl)-L-methionine ethyl ester

3-(Acetylsulphanyl)-N-[1-ethoxy-4-(methylsulphanyl)-1-oxobutan-2-yl]-2-[(2-methylphenyl)methyl]propanimidic acid

C20H29NO4S2 (411.1538)

Teloxantrone

6,8-dihydroxy-14-{2-[(2-hydroxyethyl)amino]ethyl}-10-{[2-(methylamino)ethyl]imino}-14,15-diazatetracyclo[7.6.1.0^{2,7}.0^{13,16}]hexadeca-1,4,6,8,11,13(16)-hexaen-3-one

C21H25N5O4 (411.1906)

C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C2842 - DNA Binding Agent

N-(4-((5-(3-(2-Aminoethyl)-1H-indol-5-yl)-1,2,4-oxadiazol-3-yl)methyl)phenyl)methanesulfonamide

N-[4-({5-[3-(2-aminoethyl)-1H-indol-5-yl]-1,2,4-oxadiazol-3-yl}methyl)phenyl]methanesulphonamide

C20H21N5O3S (411.1365)

Acetamide, N-(((5S)-3-(3-fluoro-4-(6-(1-methyl-1H-tetrazol-5-yl)-3-pyridinyl)phenyl)-2-oxo-5-oxazolidinyl)methyl)-

N-[(3-{3-fluoro-4-[6-(1-methyl-1H-1,2,3,4-tetrazol-5-yl)pyridin-3-yl]phenyl}-2-oxo-1,3-oxazolidin-5-yl)methyl]ethanimidate

C19H18FN7O3 (411.1455)

FR 900452

C22H25N3O3S (411.1617)

Fumaricine acetate

(-)-O-Methylfumarophycine

C23H25NO6 (411.1682)

1-O-(3-Hydroxybutyryl)pancratistatin

C18H21NO10 (411.1165)

Benarthin

C17H25N5O7 (411.1754)

A natural product found in Streptomyces speciesYM5-799 and Streptomyces xanthophaeus.

Dapholdhamine C

C23H25NO6 (411.1682)

12,13-Dihydroxyfumitremorgin C

12alpha,13alpha-Dihydroxyfumitremorgin C

C22H25N3O5 (411.1794)

An indole alkaloid that is fumitremorgin C substituted at positions 12 and 13 by hydroxy groups.

Lescol

(3R,5S)-Fluvastatin

C24H26FNO4 (411.1846)

C - Cardiovascular system > C10 - Lipid modifying agents > C10A - Lipid modifying agents, plain > C10AA - Hmg coa reductase inhibitors CONFIDENCE standard compound; INTERNAL_ID 2102 Fluvastatin (XU 62-320 free acid) is a first fully synthetic, competitive HMG-CoA reductase inhibitor with an IC50 of 8 nM. Fluvastatin protects vascular smooth muscle cells against oxidative stress through the Nrf2-dependent antioxidant pathway[1][2][3].

fluvastatin

(6E)-7-[3-(4-fluorophenyl)-1-(propan-2-yl)-1H-indol-2-yl]-3,5-dihydroxyhept-6-enoic acid

C24H26FNO4 (411.1846)

C78276 - Agent Affecting Digestive System or Metabolism > C29703 - Antilipidemic Agent C471 - Enzyme Inhibitor > C1655 - HMG-CoA Reductase Inhibitor CONFIDENCE standard compound; EAWAG_UCHEM_ID 3136 Fluvastatin (XU 62-320 free acid) is a first fully synthetic, competitive HMG-CoA reductase inhibitor with an IC50 of 8 nM. Fluvastatin protects vascular smooth muscle cells against oxidative stress through the Nrf2-dependent antioxidant pathway[1][2][3].

ACETOPHENAZINE

C23H29N3O2S (411.198)

N - Nervous system > N05 - Psycholeptics > N05A - Antipsychotics > N05AB - Phenothiazines with piperazine structure C78272 - Agent Affecting Nervous System > C29710 - Antipsychotic Agent

Lipothiazole D

C19H29N3O5S (411.1828)

C23H29N3O4_1H,5H-Imidazo[1,2:1,2]pyrido[2,3-b]indole-2,5(3H)-dione, 7a-(1,1-dimethyl-2-propen-1-yl)-7a,12-dihydro-6,12-dimethoxy-3-(1-methylethyl)

NCGC00380951-01_C23H29N3O4_1H,5H-Imidazo[1,2:1,2]pyrido[2,3-b]indole-2,5(3H)-dione, 7a-(1,1-dimethyl-2-propen-1-yl)-7a,12-dihydro-6,12-dimethoxy-3-(1-methylethyl)-

C23H29N3O4 (411.2158)

Altanserin

C22H22FN3O2S (411.1417)

Ala Ala His Asn

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-aminopropanamido]propanamido]-3-(1H-imidazol-4-yl)propanamido]-3-carbamoylpropanoic acid

C16H25N7O6 (411.1866)

Ala Ala Asn His

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-aminopropanamido]propanamido]-3-carbamoylpropanamido]-3-(1H-imidazol-4-yl)propanoic acid

C16H25N7O6 (411.1866)

Ala Gly His Gln

(2S)-2-[(2S)-2-{2-[(2S)-2-aminopropanamido]acetamido}-3-(1H-imidazol-4-yl)propanamido]-4-carbamoylbutanoic acid

C16H25N7O6 (411.1866)

Ala Gly Gln His

(2S)-2-[(2S)-2-{2-[(2S)-2-aminopropanamido]acetamido}-4-carbamoylbutanamido]-3-(1H-imidazol-4-yl)propanoic acid

C16H25N7O6 (411.1866)

Ala His Ala Asn

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-aminopropanamido]-3-(1H-imidazol-4-yl)propanamido]propanamido]-3-carbamoylpropanoic acid

C16H25N7O6 (411.1866)

Ala His Gly Gln

(2S)-2-{2-[(2S)-2-[(2S)-2-aminopropanamido]-3-(1H-imidazol-4-yl)propanamido]acetamido}-4-carbamoylbutanoic acid

C16H25N7O6 (411.1866)

Ala His Asn Ala

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-aminopropanamido]-3-(1H-imidazol-4-yl)propanamido]-3-carbamoylpropanamido]propanoic acid

C16H25N7O6 (411.1866)

Ala His Gln Gly

2-[(2S)-2-[(2S)-2-[(2S)-2-aminopropanamido]-3-(1H-imidazol-4-yl)propanamido]-4-carbamoylbutanamido]acetic acid

C16H25N7O6 (411.1866)

Ala Asn Ala His

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-aminopropanamido]-3-carbamoylpropanamido]propanamido]-3-(1H-imidazol-4-yl)propanoic acid

C16H25N7O6 (411.1866)

Ala Asn His Ala

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-aminopropanamido]-3-carbamoylpropanamido]-3-(1H-imidazol-4-yl)propanamido]propanoic acid

C16H25N7O6 (411.1866)

Ala Pro Pro Gln

(2S)-2-{[(2S)-1-{[(2S)-1-[(2S)-2-aminopropanoyl]pyrrolidin-2-yl]carbonyl}pyrrolidin-2-yl]formamido}-4-carbamoylbutanoic acid

C18H29N5O6 (411.2118)

Ala Pro Gln Pro

(2S)-1-[(2S)-2-{[(2S)-1-[(2S)-2-aminopropanoyl]pyrrolidin-2-yl]formamido}-4-carbamoylbutanoyl]pyrrolidine-2-carboxylic acid

C18H29N5O6 (411.2118)

Ala Gln Gly His

(2S)-2-{2-[(2S)-2-[(2S)-2-aminopropanamido]-4-carbamoylbutanamido]acetamido}-3-(1H-imidazol-4-yl)propanoic acid

C16H25N7O6 (411.1866)

Ala Gln His Gly

2-[(2S)-2-[(2S)-2-[(2S)-2-aminopropanamido]-4-carbamoylbutanamido]-3-(1H-imidazol-4-yl)propanamido]acetic acid

C16H25N7O6 (411.1866)

Ala Gln Pro Pro

(2S)-1-{[(2S)-1-[(2S)-2-[(2S)-2-aminopropanamido]-4-carbamoylbutanoyl]pyrrolidin-2-yl]carbonyl}pyrrolidine-2-carboxylic acid

C18H29N5O6 (411.2118)

Gly Ala His Gln

(2S)-2-[(2S)-2-[(2S)-2-(2-aminoacetamido)propanamido]-3-(1H-imidazol-4-yl)propanamido]-4-carbamoylbutanoic acid

C16H25N7O6 (411.1866)

Gly Ala Gln His

(2S)-2-[(2S)-2-[(2S)-2-(2-aminoacetamido)propanamido]-4-carbamoylbutanamido]-3-(1H-imidazol-4-yl)propanoic acid

C16H25N7O6 (411.1866)

Gly His Ala Gln

(2S)-2-[(2S)-2-[(2S)-2-(2-aminoacetamido)-3-(1H-imidazol-4-yl)propanamido]propanamido]-4-carbamoylbutanoic acid

C16H25N7O6 (411.1866)

Gly His Gln Ala

(2S)-2-[(2S)-2-[(2S)-2-(2-aminoacetamido)-3-(1H-imidazol-4-yl)propanamido]-4-carbamoylbutanamido]propanoic acid

C16H25N7O6 (411.1866)

Gly Gln Ala His

(2S)-2-[(2S)-2-[(2S)-2-(2-aminoacetamido)-4-carbamoylbutanamido]propanamido]-3-(1H-imidazol-4-yl)propanoic acid

C16H25N7O6 (411.1866)

Gly Gln His Ala

(2S)-2-[(2S)-2-[(2S)-2-(2-aminoacetamido)-4-carbamoylbutanamido]-3-(1H-imidazol-4-yl)propanamido]propanoic acid

C16H25N7O6 (411.1866)

His Ala Ala Asn

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]propanamido]propanamido]-3-carbamoylpropanoic acid

C16H25N7O6 (411.1866)

His Ala Gly Gln

(2S)-2-{2-[(2S)-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]propanamido]acetamido}-4-carbamoylbutanoic acid

C16H25N7O6 (411.1866)

His Ala Asn Ala

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]propanamido]-3-carbamoylpropanamido]propanoic acid

C16H25N7O6 (411.1866)

His Ala Gln Gly

2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]propanamido]-4-carbamoylbutanamido]acetic acid

C16H25N7O6 (411.1866)

His Gly Ala Gln

(2S)-2-[(2S)-2-{2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]acetamido}propanamido]-4-carbamoylbutanoic acid

C16H25N7O6 (411.1866)

His Gly Gln Ala

(2S)-2-[(2S)-2-{2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]acetamido}-4-carbamoylbutanamido]propanoic acid

C16H25N7O6 (411.1866)

His Asn Ala Ala

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]-3-carbamoylpropanamido]propanamido]propanoic acid

C16H25N7O6 (411.1866)

His Gln Ala Gly

2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]-4-carbamoylbutanamido]propanamido]acetic acid

C16H25N7O6 (411.1866)

His Gln Gly Ala

(2S)-2-{2-[(2S)-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]-4-carbamoylbutanamido]acetamido}propanoic acid

C16H25N7O6 (411.1866)

Phe Met Asp

C18H25N3O6S1 (411.1464)

Val Tyr Met

C19H29N3O5S1 (411.1828)

Met Met Met

C15H29N3O4S3 (411.132)

Met Val Tyr

C19H29N3O5S1 (411.1828)

Tyr Val Met

C19H29N3O5S1 (411.1828)

Asn Ala Ala His

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-carbamoylpropanamido]propanamido]propanamido]-3-(1H-imidazol-4-yl)propanoic acid

C16H25N7O6 (411.1866)

Asn Ala His Ala

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-carbamoylpropanamido]propanamido]-3-(1H-imidazol-4-yl)propanamido]propanoic acid

C16H25N7O6 (411.1866)

Asp Phe Met

C18H25N3O6S1 (411.1464)

Asn His Ala Ala

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-carbamoylpropanamido]-3-(1H-imidazol-4-yl)propanamido]propanamido]propanoic acid

C16H25N7O6 (411.1866)

Pro Ala Pro Gln

(2S)-4-carbamoyl-2-{[(2S)-1-[(2S)-2-[(2S)-pyrrolidin-2-ylformamido]propanoyl]pyrrolidin-2-yl]formamido}butanoic acid

C18H29N5O6 (411.2118)

Pro Ala Gln Pro

(2S)-1-[(2S)-4-carbamoyl-2-[(2S)-2-[(2S)-pyrrolidin-2-ylformamido]propanamido]butanoyl]pyrrolidine-2-carboxylic acid

C18H29N5O6 (411.2118)

Tyr Met Val

C19H29N3O5S1 (411.1828)

Glu Thr Tyr

C18H25N3O8 (411.1642)

Phe Asp Met

C18H25N3O6S1 (411.1464)

Pro Pro Ala Gln

(2S)-4-carbamoyl-2-[(2S)-2-{[(2S)-1-{[(2S)-pyrrolidin-2-yl]carbonyl}pyrrolidin-2-yl]formamido}propanamido]butanoic acid

C18H29N5O6 (411.2118)

Pro Pro Gln Ala

(2S)-2-[(2S)-4-carbamoyl-2-{[(2S)-1-{[(2S)-pyrrolidin-2-yl]carbonyl}pyrrolidin-2-yl]formamido}butanamido]propanoic acid

C18H29N5O6 (411.2118)

Pro Gln Ala Pro

(2S)-1-[(2S)-2-[(2S)-4-carbamoyl-2-[(2S)-pyrrolidin-2-ylformamido]butanamido]propanoyl]pyrrolidine-2-carboxylic acid

C18H29N5O6 (411.2118)

Pro Gln Pro Ala

(2S)-2-{[(2S)-1-[(2S)-4-carbamoyl-2-[(2S)-pyrrolidin-2-ylformamido]butanoyl]pyrrolidin-2-yl]formamido}propanoic acid

C18H29N5O6 (411.2118)

Gln Ala Gly His

(2S)-2-{2-[(2S)-2-[(2S)-2-amino-4-carbamoylbutanamido]propanamido]acetamido}-3-(1H-imidazol-4-yl)propanoic acid

C16H25N7O6 (411.1866)

Gln Ala His Gly

2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-carbamoylbutanamido]propanamido]-3-(1H-imidazol-4-yl)propanamido]acetic acid

C16H25N7O6 (411.1866)

Gln Ala Pro Pro

(2S)-1-{[(2S)-1-[(2S)-2-[(2S)-2-amino-4-carbamoylbutanamido]propanoyl]pyrrolidin-2-yl]carbonyl}pyrrolidine-2-carboxylic acid

C18H29N5O6 (411.2118)

Val Met Tyr

C19H29N3O5S1 (411.1828)

Phe Val Phe

C23H29N3O4 (411.2158)

Gln Gly Ala His

(2S)-2-[(2S)-2-{2-[(2S)-2-amino-4-carbamoylbutanamido]acetamido}propanamido]-3-(1H-imidazol-4-yl)propanoic acid

C16H25N7O6 (411.1866)

Gln Gly His Ala

(2S)-2-[(2S)-2-{2-[(2S)-2-amino-4-carbamoylbutanamido]acetamido}-3-(1H-imidazol-4-yl)propanamido]propanoic acid

C16H25N7O6 (411.1866)

Gln His Ala Gly

2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-carbamoylbutanamido]-3-(1H-imidazol-4-yl)propanamido]propanamido]acetic acid

C16H25N7O6 (411.1866)

Gln His Gly Ala

(2S)-2-{2-[(2S)-2-[(2S)-2-amino-4-carbamoylbutanamido]-3-(1H-imidazol-4-yl)propanamido]acetamido}propanoic acid

C16H25N7O6 (411.1866)

Glu Tyr Thr

C18H25N3O8 (411.1642)

Gln Pro Ala Pro

(2S)-1-[(2S)-2-{[(2S)-1-[(2S)-2-amino-4-carbamoylbutanoyl]pyrrolidin-2-yl]formamido}propanoyl]pyrrolidine-2-carboxylic acid

C18H29N5O6 (411.2118)

Gln Pro Pro Ala

(2S)-2-{[(2S)-1-{[(2S)-1-[(2S)-2-amino-4-carbamoylbutanoyl]pyrrolidin-2-yl]carbonyl}pyrrolidin-2-yl]formamido}propanoic acid

C18H29N5O6 (411.2118)

Met Phe Asp

C18H25N3O6S1 (411.1464)

Met Asp Phe

C18H25N3O6S1 (411.1464)

Met Tyr Val

C19H29N3O5S1 (411.1828)

Asp Met Phe

C18H25N3O6S1 (411.1464)

Galβ1-4Glcβ-Sp

C14H25N3O11 (411.1489)

PE(6:0/6:0)

Hexanoic acid, 1-[[[(2-aminoethoxy)hydroxyphosphinyl]oxy]methyl]-1,2-ethanediyl ester, (R)-

C17H34NO8P (411.2022)

Dihexanoyl-alpha-ph

Hexanoin, 1,2-di-, 3-(dihydrogen phosphate), 2-aminoethyl ester

C17H34NO8P (411.2022)

Val-Trp-OH

(S)-3-(1H-indol-3-yl)-2-(3-isopropoxy-4-nitrobenzamido)propanoic acid

C21H21N3O6 (411.143)

Trp-Abu-OH

(S)-2-(3-(2-(1H-indol-3-yl)ethoxy)-4-nitrobenzamido)pentanoic acid

C21H21N3O6 (411.143)

Carphenazine

1-(10-{2-[4-(2-hydroxyethyl)piperazin-1-yl]ethyl}-10H-phenothiazin-2-yl)propan-1-one

C23H29N3O2S (411.198)

Tasosartan

2,4-dimethyl-8-({4-[2-(2H-1,2,3,4-tetrazol-5-yl)phenyl]phenyl}methyl)-5H,6H,7H,8H-pyrido[2,3-d]pyrimidin-7-one

C23H21N7O (411.1807)

C - Cardiovascular system > C09 - Agents acting on the renin-angiotensin system > C09C - Angiotensin ii receptor blockers (arbs), plain > C09CA - Angiotensin ii receptor blockers (arbs), plain C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent > C66930 - Angiotensin II Receptor Antagonist D057911 - Angiotensin Receptor Antagonists > D047228 - Angiotensin II Type 1 Receptor Blockers Tasosartan is a long-acting angiotensin II (AngII) receptor antagonist.

7-Formyldehydrothalicsimidine

4,5,14,15,16-pentamethoxy-10-methyl-10-azatetracyclo[7.7.1.0^{2,7}.0^{13,17}]heptadeca-1(16),2,4,6,8,13(17),14-heptaene-8-carbaldehyde

C23H25NO6 (411.1682)

6-HydroxyKetanserin

C22H22FN3O4 (411.1594)

Dihydroxyfumitremorgin C

1,2-dihydroxy-7-methoxy-12-(2-methylprop-1-en-1-yl)-10,13,19-triazapentacyclo[11.7.0.0^{3,11}.0^{4,9}.0^{15,19}]icosa-3(11),4,6,8-tetraene-14,20-dione

C22H25N3O5 (411.1794)

PE 12:0

Hexanoic acid, 1-[[[(2-aminoethoxy)hydroxyphosphinyl]oxy]methyl]-1,2-ethanediyl ester, (R)-

C17H34NO8P (411.2022)

(4-(N-Benzyl-N-(4-methoxybenzyl)sulfamoyl)phenyl)boronic acid

C21H22BNO5S (411.1312)

N-(2-chloroethyl)-1-(2-methoxyphenyl)-N-[1-(2-methoxyphenyl)propan-2-yl]propan-2-amine

C22H31Cl2NO2 (411.1732)

2-N,N-bis(tert-Butoxycarbonyl)amino-4,5,6,7-tetrahydro-benzo[b]thiophene-3-carboxylic acid Methyl ester

C20H29NO6S (411.1715)

3-[3-(3-hydroxy-2-phenylpropanoyl)oxy-8-methyl-8-azoniabicyclo[3.2.1]octan-8-yl]propane-1-sulfonate

C20H29NO6S (411.1715)

Cadrofloxacin

C19H20F3N3O4 (411.1406)

2,3,5-TRI-O-ACETYL-8-FLUORO ADENOSINE

C16H18FN5O7 (411.119)

3-Butyl-1,1,2-trimethyl-1H-benzo[e]indolium hexafluorophosphate

C19H24F6NP (411.155)

FMOC-ASP(OTBU)-OH

C23H25NO6 (411.1682)

2-Methyl-2-propanyl (3Z,5Z)-3,5-bis(4-fluorobenzylidene)-4-oxo-1- piperidinecarboxylate

C24H23F2NO3 (411.1646)

JAK2 inhibitor G5-7

C24H23F2NO3 (411.1646)

fmoc-d-aspartic acid β-tert-butyl ester

C23H25NO6 (411.1682)

sacubitril

C24H29NO5 (411.2046)

C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent

JTC-801 free base

N-(4-amino-2-methylquinolin-6-yl)-2-[(4-ethylphenoxy)methyl]benzamide

C26H25N3O2 (411.1947)

4-Aminodibenzo-18-crown-6 hydrochloride

C20H26ClNO6 (411.1449)

(2s,4s)-1-t-butoxycarbonyl-2-(N-T-butoxycarbonyl-N-sulfamoylamino)methyl-4-mercapto-pyrrolidine

C15H29N3O6S2 (411.1498)

O-benzyl-L-methionine toluene-p-sulphonate

C19H25NO5S2 (411.1174)

Fmoc-Asp-OtBu

C23H25NO6 (411.1682)

Fmoc-D-Asp(OtBu)-OH

C23H25NO6 (411.1682)

Fmoc-D-Asu-OH

C23H25NO6 (411.1682)

fmoc-asu-oh

C23H25NO6 (411.1682)

4(1H)-Pyridazinone, 6-methyl-3-(2-quinolinylmethoxy)-1-(3-(trifluorome thyl)phenyl)-

C22H16F3N3O2 (411.1195)

Methyl 1-((2-cyano-[1,1-biphenyl]-4-yl)methyl)-2-ethoxy-1H-benzo[d]imidazole-7-carboxylate

C25H21N3O3 (411.1583)

FMOC-L-BETA-HOMOTHREONINE(OTBU)

C24H29NO5 (411.2046)

2-[(2-cyanoethyl)[4-[(2-hydroxy-4-nitrophenyl)azo]-m-tolyl]amino]ethyl acetate

C20H21N5O5 (411.1543)

Fmoc-gly-gly-gly-oh

C21H21N3O6 (411.143)

(2S)-2-(9H-fluoren-9-ylmethoxycarbonylamino)-4-[(2-methylpropan-2-yl)oxy]-4-oxobutanoic acid

C23H25NO6 (411.1682)

Fmoc-nAsp(OtBu)-OH

C23H25NO6 (411.1682)

BOC-ASP-OFM

C23H25NO6 (411.1682)

2-(3-(1-Benzylpiperidin-4-yl)-2-oxopropyl)-4,5-dimethoxybenzoic Acid

C24H29NO5 (411.2046)

1-(2-ethylhexyl)-1,2-dihydro-6-hydroxy-4-methyl-5-[(2-nitrophenyl)azo]-2-oxonicotinonitrile

C21H25N5O4 (411.1906)

9-(3-(CIS-3 5-DIMETHYL-1-PIPERAZINYL)-

C21H31Cl2N3O (411.1844)

Dobupride

C20H30ClN3O4 (411.1925)

2,3,5-Tri-O-acetyl-2-fluoroadenosine

C16H18FN5O7 (411.119)

Fmoc-N-Me-Thr(tBu)-OH

C24H29NO5 (411.2046)

L-694247

N-(4-((5-(3-(2-Aminoethyl)-1H-indol-5-yl)-1,2,4-oxadiazol-3-yl)methyl)phenyl)methanesulfonamide

C20H21N5O3S (411.1365)

PKCβ inhibitor 1

PKCbeta Inhibitor

C24H21N5O2 (411.1695)

Phenol,2-[4,6-bis(2,4-dimethylphenyl)-1,3,5-triazin-2-yl]-5-Methoxy

C26H25N3O2 (411.1947)

2R,4S-Sacubitril

C24H29NO5 (411.2046)

Boc-asp(ofm)-oh

C23H25NO6 (411.1682)

(R)-3-[1-(4-Fluoro-benzyl)-1H-benzoiMidazol-2-yloxy]-pyrrolidine-1-carboxylic acid tert-butyl ester

C23H26FN3O3 (411.1958)

(2R,4S)-4-([1,1-Biphenyl]-4-ylmethyl)-4-(4-ethoxy-4-oxobutanamido)-2-methylbutanoic acid

C24H29NO5 (411.2046)

Fmoc-D-hcit-OH

C22H25N3O5 (411.1794)

Trimethionine

H-Met-Met-Met-OH

C15H29N3O4S3 (411.132)

9-Mesityl-10-methylacridinium perchlorate

C23H22ClNO4 (411.1237)

Bimiralisib

C17H20F3N7O2 (411.163)

C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C2152 - Phosphatidylinositide 3-Kinase Inhibitor C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor C274 - Antineoplastic Agent > C1742 - Angiogenesis Inhibitor C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor Bimiralisib (PQR309) is a potent, brain-penetrant, orally bioavailable, pan-class I PI3K/mTOR inhibitor with IC50s of 33 nM, 451 nM, 661 nM, 708 nM and 89 nM for PI3Kα, PI3Kδ, PI3Kβ, PI3Kγ and mTOR, respectively. Bimiralisib is an mTORC1 and mTORC2 inhibitor. Bimiralisib (PQR309) is a potent, brain-penetrant, orally bioavailable, pan-class I PI3K/mTOR inhibitor with IC50s of 33 nM, 451 nM, 661 nM, 708 nM and 89 nM for PI3Kα, PI3Kδ, PI3Kβ, PI3Kγ and mTOR, respectively. Bimiralisib is an mTORC1 and mTORC2 inhibitor.

3-(1,1-Dioxido-4h-1,2,4-Benzothiadiazin-3-Yl)-4-Hydroxy-1-(3-Methylbutyl)quinolin-2(1h)-One

C21H21N3O4S (411.1253)

Nalmefene hydrochloride dihydrate

C21H30ClNO5 (411.1812)

AHU-377(Sacubitril)

C24H29NO5 (411.2046)

Pizotifen maleate

C23H25NO4S (411.1504)

Fluvastatin sodium anti-isomer free acid

C24H26FNO4 (411.1846)

rac N,N-Didesmethyl-O-desmethyl Venlafaxine Glucuronide

C20H29NO8 (411.1893)

GSK-J1SodiumSalt

C22H22N5NaO2 (411.1671)

1-(2,4-Dimethoxyphenyl)-3-[4-(4-morpholinyl)anilino]pyrrolidine-2,5-dione

C22H25N3O5 (411.1794)

4-(dimethylsulfamoyl)-N-(6,7,8,9-tetrahydro-5H-carbazol-3-ylmethyl)benzamide

C22H25N3O3S (411.1617)

Difeterol hydrochloride

C25H30ClNO2 (411.1965)

H-Glu-Thr-Tyr-OH

C18H25N3O8 (411.1642)

6-[(Z)-Amino(imino)methyl]-N-[4-(aminomethyl)phenyl]-4-(pyrimidin-2-ylamino)-2-naphthamide

C23H21N7O (411.1807)

5-(6-d-Ribitylamino-2,4-dihydroxypyrimidin-5-yl)-1-pentyl-phosphonic acid

C14H26N3O9P (411.1407)

S-{3-[(4-Anilinoquinazolin-6-YL)amino]-3-oxopropyl}-L-cysteine

C20H21N5O3S (411.1365)

4-[(3R)-3-amino-4-(2,4,5-trifluorophenyl)butanoyl]-3-(2,2,2-trifluoroethyl)-1,4-diazepan-2-one

C17H19F6N3O2 (411.1381)

Entospletinib

C23H21N7O (411.1807)

1-[10-[3-[4-(2-Hydroxyethyl)piperazin-1-yl]propyl]phenothiazin-3-yl]ethanone

C23H29N3O2S (411.198)

N-(2(S)-(Acetylthiomethyl)-3-(2-methylphenyl)-1-oxopropyl)-L-methionine ethyl ester

3-(Acetylsulphanyl)-N-[1-ethoxy-4-(methylsulphanyl)-1-oxobutan-2-yl]-2-[(2-methylphenyl)methyl]propanimidic acid

C20H29NO4S2 (411.1538)

4-hydroxy-rot-2-enonate

C23H23O7- (411.1444)

5-Hydroxy-rot-2-enonate

C23H23O7- (411.1444)

(2R,3R,4S,7S)-3-[(3R,4R)-3,4-dihydroxypentanoyl]oxy-7-(3-hydroxyphenyl)-7-methoxy-2,4-dimethylheptanoate

C21H31O8- (411.2019)

D009676 - Noxae > D011042 - Poisons > D008235 - Lyngbya Toxins D009676 - Noxae > D011042 - Poisons > D008387 - Marine Toxins

N-[[3-[3-fluoro-4-[6-(1-methyltetrazol-5-yl)pyridin-3-yl]phenyl]-2-oxo-1,3-oxazolidin-5-yl]methyl]acetamide

C19H18FN7O3 (411.1455)

(3S,5S,6E)-7-[3-(4-fluorophenyl)-1-(propan-2-yl)-1H-indol-2-yl]-3,5-dihydroxyhept-6-enoic acid

C24H26FNO4 (411.1846)

(6-chloro-2,3,4,9-tetrahydro-1H-carbazol-1-yl)-[4-[2-furanyl(oxo)methyl]-1-piperazinyl]methanone

C22H22ClN3O3 (411.135)

2-azaniumylethyl (2R)-2,3-bis(hexanoyloxy)propyl phosphate

C17H34NO8P (411.2022)

(S)-mandipropamid

C23H22ClNO4 (411.1237)

Dichotomide XII, (rel)-

C21H21N3O6 (411.143)

A natural product found in Stellaria dichotoma var. lanceolata.

N-[3-(4-methyl-1-piperazinyl)-1,4-dioxo-2-naphthalenyl]benzenesulfonamide

C21H21N3O4S (411.1253)

1-(5-tert-butyl-1,2-oxazol-3-yl)-3-[3-fluoro-4-(1H-pyrazolo[3,4-d]pyrimidin-4-yloxy)phenyl]urea

C19H18FN7O3 (411.1455)

2-(1,5-Dimethyl-3-oxo-2-phenyl-4-pyrazolyl)-3-hydroxy-3-phenyl-1-isoindolone

C25H21N3O3 (411.1583)

4-[3-[4-[2-Furanyl(oxo)methyl]-1-piperazinyl]-2,5-dioxo-1-pyrrolidinyl]benzoic acid methyl ester

C21H21N3O6 (411.143)

2,11-Dimethoxy-9-(2-methylbut-3-en-2-yl)-14-propan-2-yl-2,13,16-triazatetracyclo[7.7.0.01,13.03,8]hexadeca-3,5,7,10-tetraene-12,15-dione

C23H29N3O4 (411.2158)

Thr-Glu-Tyr

C18H25N3O8 (411.1642)

5-cyclopropyl-N-(4,5,6,7-tetrahydro-1,3-benzothiazol-2-yl)-7-(trifluoromethyl)-1,5,6,7-tetrahydropyrazolo[1,5-a]pyrimidine-2-carboxamide

C18H20F3N5OS (411.1341)

3-[3-[4-(4-methoxyphenyl)-1-piperazinyl]propyl]-2-sulfanylidene-1H-pyrido[2,3-d]pyrimidin-4-one

C21H25N5O2S (411.1729)

N-[2-(2,3-dimethylphenyl)-5,5-dioxo-4,6-dihydrothieno[3,4-c]pyrazol-3-yl]-2-methoxybenzamide

C21H21N3O4S (411.1253)

5-Nitro-2-[(phenylmethyl)amino]benzoic acid [2-(cyclohexylamino)-2-oxoethyl] ester

C22H25N3O5 (411.1794)

(3R)-3-(2-fluoro-5-methylphenyl)-7-phenyl-2-(phenylmethyl)-3a,6,7,7a-tetrahydro-3H-isoindol-1-one

C28H26FNO (411.1998)

N-(3,4-dimethylphenyl)-2-[[5-[3-(4-methoxyphenyl)propyl]-1,3,4-oxadiazol-2-yl]thio]acetamide

C22H25N3O3S (411.1617)

(E)-3-(4-methoxyphenyl)-N-[4-(2-methoxyphenyl)piperazine-1-carbothioyl]prop-2-enamide

C22H25N3O3S (411.1617)

1-(3,5-Dimethyl-1-piperidinyl)-2-[[2-(thiophen-2-ylmethyl)-4-quinazolinyl]thio]ethanone

C22H25N3OS2 (411.1439)

2-(3-ethylphenoxy)-N-[4-(2-pyridinylsulfamoyl)phenyl]acetamide

C21H21N3O4S (411.1253)

3-Nitro-4-(1-pyrrolidinyl)benzoic acid [1-(4-ethylanilino)-1-oxopropan-2-yl] ester

C22H25N3O5 (411.1794)

5-(4-Ethoxyphenyl)-1,3-diphenyl-3a,6a-dihydropyrrolo[3,4-c]pyrazole-4,6-dione

C25H21N3O3 (411.1583)

2-[2-(6,7-dimethoxy-3,4-dihydro-1H-isoquinolin-2-yl)-2-oxoethyl]sulfanyl-6-ethyl-5-methylpyridine-3-carbonitrile

C22H25N3O3S (411.1617)

6-(7,8-dimethoxy-1-methyl-3-phenyl-2H-pyrazolo[3,4-c]isoquinolin-5-ylidene)-1-cyclohexa-2,4-dienone

C25H21N3O3 (411.1583)

2-(4-Ethoxy-3-methoxyphenyl)-3-(4-methoxyphenyl)-6-oxo-4-sulfanyl-1,2-dihydropyrimidine-5-carbonitrile

C21H21N3O4S (411.1253)

2-[4-[(6-Ethoxy-2-quinolinyl)methyl]-1-(3-thiophenylmethyl)-2-piperazinyl]ethanol

C23H29N3O2S (411.198)

N,N-(6-((4-(hydroxy(phenyl)methyl)phenyl)amino)-6-oxohexane-1,5-diyl)diacetamide

C23H29N3O4 (411.2158)

4-[[7-Methyl-4-(phenylthio)-5,6,7,8-tetrahydro-[1]benzothiolo[2,3-d]pyrimidin-2-yl]methyl]morpholine

C22H25N3OS2 (411.1439)

[2-(2-Methoxyethyl)-1-piperidinyl]-[5-[[4-(1,2,4-triazol-1-yl)phenoxy]methyl]-3-isoxazolyl]methanone

C21H25N5O4 (411.1906)

2-[(5,6-Dimethyl-2-propyl-4-thieno[2,3-d]pyrimidinyl)thio]-1-(2-methyl-2,3-dihydroindol-1-yl)ethanone

C22H25N3OS2 (411.1439)

19-O-acetylhorhammericine

C23H27N2O5+ (411.192)

(E)-2-(1H-benzimidazol-2-yl)-N-(furan-2-ylmethyl)-3-[3-(trifluoromethyl)phenyl]prop-2-enamide

C22H16F3N3O2 (411.1195)

N-{[(1S,2R)-1-carboxylato-2-hydroxypropyl]carbamoyl}adenosine

C15H19N6O8- (411.1264)

17-Hydroxy-20-oxopregn-5-en-3beta-yl sulfate

C21H31O6S- (411.1841)

2-(9-Oxononanoyl)-sn-glycero-3-phosphocholine

C17H34NO8P (411.2022)

Dnp-Nor-Gln

C16H21N5O8 (411.139)

Glu-Tyr-Thr

C18H25N3O8 (411.1642)

Met-Val-Tyr

C19H29N3O5S (411.1828)

Val-Phe-Phe

C23H29N3O4 (411.2158)

Asp-Tyr-Asp

C17H21N3O9 (411.1278)

Met-Asp-Phe

C18H25N3O6S (411.1464)

Thr-Tyr-Glu

C18H25N3O8 (411.1642)

Tyr-Asp-Asp

C17H21N3O9 (411.1278)

(R)-mandipropamid

C23H22ClNO4 (411.1237)

Phe-val-phe

C23H29N3O4 (411.2158)

(2S,3S,4S)-3-[4-[2-(2-fluorophenyl)ethynyl]phenyl]-4-(hydroxymethyl)-1-(pyridine-3-carbonyl)azetidine-2-carbonitrile

C25H18FN3O2 (411.1383)

2-[(2R,5R,6S)-6-(hydroxymethyl)-5-[[1-oxo-2-(2-pyridinyl)ethyl]amino]-2-oxanyl]-N-[(1S)-1-phenylethyl]acetamide

C23H29N3O4 (411.2158)

N-[(1R,3S,4aR,9aS)-3-[2-(dimethylamino)-2-oxoethyl]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-3-pyridinecarboxamide

C22H25N3O5 (411.1794)

(2R,3S,4S)-3-[4-[2-(2-fluorophenyl)ethynyl]phenyl]-4-(hydroxymethyl)-1-(pyridine-3-carbonyl)azetidine-2-carbonitrile

C25H18FN3O2 (411.1383)

(2R,3S,4R)-3-[4-[2-(2-fluorophenyl)ethynyl]phenyl]-4-(hydroxymethyl)-1-[oxo(3-pyridinyl)methyl]-2-azetidinecarbonitrile

C25H18FN3O2 (411.1383)

N-[(1S,3R,4aS,9aR)-3-[2-(dimethylamino)-2-oxoethyl]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b][1]benzofuran-6-yl]pyridine-3-carboxamide

C22H25N3O5 (411.1794)

(2S,3R,4S)-3-[4-[2-(2-fluorophenyl)ethynyl]phenyl]-4-(hydroxymethyl)-1-[oxo(3-pyridinyl)methyl]-2-azetidinecarbonitrile

C25H18FN3O2 (411.1383)

(2S,3R,4R)-3-[4-[2-(2-fluorophenyl)ethynyl]phenyl]-4-(hydroxymethyl)-1-[oxo(3-pyridinyl)methyl]-2-azetidinecarbonitrile

C25H18FN3O2 (411.1383)

N-[(1R,3R,4aR,9aS)-3-[2-(dimethylamino)-2-oxoethyl]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b][1]benzofuran-6-yl]pyridine-3-carboxamide

C22H25N3O5 (411.1794)

(2R,3R,4R)-3-[4-[2-(2-fluorophenyl)ethynyl]phenyl]-4-(hydroxymethyl)-1-[oxo(3-pyridinyl)methyl]-2-azetidinecarbonitrile

C25H18FN3O2 (411.1383)

(2R,3R,3aS,9bS)-7-(cyclopenten-1-yl)-1-(cyclopropanecarbonyl)-N-ethyl-3-(hydroxymethyl)-6-oxo-3,3a,4,9b-tetrahydro-2H-pyrrolo[2,3-a]indolizine-2-carboxamide

C23H29N3O4 (411.2158)

(1S,9R,10R,11R)-N-cyclobutyl-5-(4-fluorophenyl)-10-(hydroxymethyl)-12-methyl-6-oxo-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-diene-11-carboxamide

C23H26FN3O3 (411.1958)

(2R,3R,3aS,9bS)-N-benzyl-3-(hydroxymethyl)-1-(2-methoxyacetyl)-6-oxo-3,3a,4,9b-tetrahydro-2H-pyrrolo[2,3-a]indolizine-2-carboxamide

C22H25N3O5 (411.1794)

Sodium 3-[[2-pyridin-3-yl-6-(1,2,4,5-tetrahydro-3-benzazepin-3-yl)pyrimidin-4-yl]amino]propanoate

C22H22N5NaO2 (411.1671)

(2R,3S)-8-[2-(2-fluorophenyl)ethynyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one

C23H26FN3O3 (411.1958)

(2S,3R)-8-[2-(2-fluorophenyl)ethynyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one

C23H26FN3O3 (411.1958)

2-[(2S,3R,6R)-3-(benzenesulfonamido)-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]-N-[3-(dimethylamino)propyl]acetamide

C19H29N3O5S (411.1828)

2-[(2R,3S,6R)-3-(benzenesulfonamido)-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]-N-[3-(dimethylamino)propyl]acetamide

C19H29N3O5S (411.1828)

2-[(2R,3R,6S)-3-(benzenesulfonamido)-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]-N-[3-(dimethylamino)propyl]acetamide

C19H29N3O5S (411.1828)

2-[(2R,5S,6R)-6-(hydroxymethyl)-5-[[1-oxo-2-(2-pyridinyl)ethyl]amino]-2-oxanyl]-N-[(1S)-1-phenylethyl]acetamide

C23H29N3O4 (411.2158)

2-[(2S,5S,6R)-6-(hydroxymethyl)-5-[[1-oxo-2-(2-pyridinyl)ethyl]amino]-2-oxanyl]-N-[(1S)-1-phenylethyl]acetamide

C23H29N3O4 (411.2158)

2-[(2S,5S,6R)-6-(hydroxymethyl)-5-[[1-oxo-2-(2-pyridinyl)ethyl]amino]-2-oxanyl]-N-[(1R)-1-phenylethyl]acetamide

C23H29N3O4 (411.2158)

2-[(2S,5S,6S)-6-(hydroxymethyl)-5-[[1-oxo-2-(2-pyridinyl)ethyl]amino]-2-oxanyl]-N-[(1S)-1-phenylethyl]acetamide

C23H29N3O4 (411.2158)

2-[(2R,5R,6R)-6-(hydroxymethyl)-5-[[1-oxo-2-(2-pyridinyl)ethyl]amino]-2-oxanyl]-N-[(1S)-1-phenylethyl]acetamide

C23H29N3O4 (411.2158)

2-[(2S,5R,6R)-6-(hydroxymethyl)-5-[[1-oxo-2-(2-pyridinyl)ethyl]amino]-2-oxanyl]-N-[(1R)-1-phenylethyl]acetamide

C23H29N3O4 (411.2158)

(1R,2aS,8bS)-N-(4-chlorophenyl)-2-[cyclopropyl(oxo)methyl]-1-(hydroxymethyl)-1,2a,3,8b-tetrahydroazeto[2,3-c]quinoline-4-carboxamide

C22H22ClN3O3 (411.135)

(1S,2aR,8bR)-N-(4-chlorophenyl)-2-[cyclopropyl(oxo)methyl]-1-(hydroxymethyl)-1,2a,3,8b-tetrahydroazeto[2,3-c]quinoline-4-carboxamide

C22H22ClN3O3 (411.135)

(2S,3S,3aR,9bR)-7-(1-cyclopentenyl)-1-[cyclopropyl(oxo)methyl]-N-ethyl-3-(hydroxymethyl)-6-oxo-3,3a,4,9b-tetrahydro-2H-pyrrolo[2,3-a]indolizine-2-carboxamide

C23H29N3O4 (411.2158)

(1R,9S,10S,11S)-N-cyclobutyl-5-(4-fluorophenyl)-10-(hydroxymethyl)-12-methyl-6-oxo-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-diene-11-carboxamide

C23H26FN3O3 (411.1958)

(2S,3S,3aR,9bR)-3-(hydroxymethyl)-1-(2-methoxy-1-oxoethyl)-6-oxo-N-(phenylmethyl)-3,3a,4,9b-tetrahydro-2H-pyrrolo[2,3-a]indolizine-2-carboxamide

C22H25N3O5 (411.1794)

[(1S)-2-[(3-chlorophenyl)methyl]-7-methoxy-1-methyl-1-spiro[3,9-dihydro-1H-pyrido[3,4-b]indole-4,3-azetidine]yl]methanol

C23H26ClN3O2 (411.1713)

[(1S)-1-[(4-chlorophenyl)methyl]-7-methoxy-9-methyl-1-spiro[2,3-dihydro-1H-pyrido[3,4-b]indole-4,3-azetidine]yl]methanol

C23H26ClN3O2 (411.1713)

(6S,7S,8S)-7-[4-(4-fluorophenyl)phenyl]-8-(hydroxymethyl)-2-oxo-N-propyl-1,4-diazabicyclo[4.2.0]octane-4-carboxamide

C23H26FN3O3 (411.1958)

(6R,7R,8R)-7-[4-(4-fluorophenyl)phenyl]-8-(hydroxymethyl)-2-oxo-N-propyl-1,4-diazabicyclo[4.2.0]octane-4-carboxamide

C23H26FN3O3 (411.1958)

(6S,7R,8R)-7-[4-(4-fluorophenyl)phenyl]-8-(hydroxymethyl)-2-oxo-N-propyl-1,4-diazabicyclo[4.2.0]octane-4-carboxamide

C23H26FN3O3 (411.1958)

2-(dimethylamino)-1-[(2S,3R)-6-[(4-fluorophenyl)-oxomethyl]-2-(hydroxymethyl)-3-phenyl-1,6-diazaspiro[3.3]heptan-1-yl]ethanone

C23H26FN3O3 (411.1958)

(2S,3R)-8-[2-(2-fluorophenyl)ethynyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one

C23H26FN3O3 (411.1958)

(2R,3S)-8-[2-(2-fluorophenyl)ethynyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one

C23H26FN3O3 (411.1958)

2-[(2R,3S,6S)-3-(benzenesulfonamido)-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]-N-[3-(dimethylamino)propyl]acetamide

C19H29N3O5S (411.1828)

2-[(2S,3R,6S)-3-(benzenesulfonamido)-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]-N-[3-(dimethylamino)propyl]acetamide

C19H29N3O5S (411.1828)

2-[(2S,3S,6R)-3-(benzenesulfonamido)-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]-N-[3-(dimethylamino)propyl]acetamide

C19H29N3O5S (411.1828)

2-[(2S,3S,6S)-3-(benzenesulfonamido)-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]-N-[3-(dimethylamino)propyl]acetamide

C19H29N3O5S (411.1828)

2-[(2R,3R,6R)-3-(benzenesulfonamido)-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]-N-[3-(dimethylamino)propyl]acetamide

C19H29N3O5S (411.1828)

2-[(2S,5R,6S)-6-(hydroxymethyl)-5-[[1-oxo-2-(2-pyridinyl)ethyl]amino]-2-oxanyl]-N-[(1R)-1-phenylethyl]acetamide

C23H29N3O4 (411.2158)

2-[(2S,5R,6S)-6-(hydroxymethyl)-5-[[1-oxo-2-(2-pyridinyl)ethyl]amino]-2-oxanyl]-N-[(1S)-1-phenylethyl]acetamide

C23H29N3O4 (411.2158)

2-[(2R,5S,6R)-6-(hydroxymethyl)-5-[[1-oxo-2-(2-pyridinyl)ethyl]amino]-2-oxanyl]-N-[(1R)-1-phenylethyl]acetamide

C23H29N3O4 (411.2158)

2-[(2R,5R,6S)-6-(hydroxymethyl)-5-[[1-oxo-2-(2-pyridinyl)ethyl]amino]-2-oxanyl]-N-[(1R)-1-phenylethyl]acetamide

C23H29N3O4 (411.2158)

2-[(2S,5S,6S)-6-(hydroxymethyl)-5-[[1-oxo-2-(2-pyridinyl)ethyl]amino]-2-oxanyl]-N-[(1R)-1-phenylethyl]acetamide

C23H29N3O4 (411.2158)

2-[(2R,5R,6R)-6-(hydroxymethyl)-5-[[1-oxo-2-(2-pyridinyl)ethyl]amino]-2-oxanyl]-N-[(1R)-1-phenylethyl]acetamide

C23H29N3O4 (411.2158)

2-[(2R,5S,6S)-6-(hydroxymethyl)-5-[[1-oxo-2-(2-pyridinyl)ethyl]amino]-2-oxanyl]-N-[(1S)-1-phenylethyl]acetamide

C23H29N3O4 (411.2158)

2-[(2R,5S,6S)-6-(hydroxymethyl)-5-[[1-oxo-2-(2-pyridinyl)ethyl]amino]-2-oxanyl]-N-[(1R)-1-phenylethyl]acetamide

C23H29N3O4 (411.2158)

2-[(2S,5R,6R)-6-(hydroxymethyl)-5-[[1-oxo-2-(2-pyridinyl)ethyl]amino]-2-oxanyl]-N-[(1S)-1-phenylethyl]acetamide

C23H29N3O4 (411.2158)

N-[(1S,3S,4aS,9aR)-3-[2-(dimethylamino)-2-oxoethyl]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-3-pyridinecarboxamide

C22H25N3O5 (411.1794)

N-[(1R,3R,4aS,9aR)-3-[2-(dimethylamino)-2-oxoethyl]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-3-pyridinecarboxamide

C22H25N3O5 (411.1794)

N-[(1S,3S,4aR,9aS)-3-[2-(dimethylamino)-2-oxoethyl]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-3-pyridinecarboxamide

C22H25N3O5 (411.1794)

(2S,3S,4R)-3-[4-[2-(2-fluorophenyl)ethynyl]phenyl]-4-(hydroxymethyl)-1-[oxo(3-pyridinyl)methyl]-2-azetidinecarbonitrile

C25H18FN3O2 (411.1383)

(1S,2aS,8bS)-N-(4-chlorophenyl)-2-[cyclopropyl(oxo)methyl]-1-(hydroxymethyl)-1,2a,3,8b-tetrahydroazeto[2,3-c]quinoline-4-carboxamide

C22H22ClN3O3 (411.135)

(1R,2aR,8bR)-N-(4-chlorophenyl)-2-[cyclopropyl(oxo)methyl]-1-(hydroxymethyl)-1,2a,3,8b-tetrahydroazeto[2,3-c]quinoline-4-carboxamide

C22H22ClN3O3 (411.135)

[(1R)-1-[(2-chlorophenyl)methyl]-7-methoxy-9-methyl-1-spiro[2,3-dihydro-1H-pyrido[3,4-b]indole-4,3-azetidine]yl]methanol

C23H26ClN3O2 (411.1713)

[(1S)-1-[(2-chlorophenyl)methyl]-7-methoxy-9-methyl-1-spiro[2,3-dihydro-1H-pyrido[3,4-b]indole-4,3-azetidine]yl]methanol

C23H26ClN3O2 (411.1713)

(6S,7R,8S)-7-[4-(4-fluorophenyl)phenyl]-8-(hydroxymethyl)-2-oxo-N-propyl-1,4-diazabicyclo[4.2.0]octane-4-carboxamide

C23H26FN3O3 (411.1958)

(6S,7S,8R)-7-[4-(4-fluorophenyl)phenyl]-8-(hydroxymethyl)-2-oxo-N-propyl-1,4-diazabicyclo[4.2.0]octane-4-carboxamide

C23H26FN3O3 (411.1958)

(6R,7S,8S)-7-[4-(4-fluorophenyl)phenyl]-8-(hydroxymethyl)-2-oxo-N-propyl-1,4-diazabicyclo[4.2.0]octane-4-carboxamide

C23H26FN3O3 (411.1958)

(6R,7R,8S)-7-[4-(4-fluorophenyl)phenyl]-8-(hydroxymethyl)-2-oxo-N-propyl-1,4-diazabicyclo[4.2.0]octane-4-carboxamide

C23H26FN3O3 (411.1958)

Phe-Phe-Val

C23H29N3O4 (411.2158)

Asp-Asp-Tyr

C17H21N3O9 (411.1278)

Asp-Phe-Met

C18H25N3O6S (411.1464)

Met-Phe-Asp

C18H25N3O6S (411.1464)

Tyr-Glu-Thr

C18H25N3O8 (411.1642)

Tyr-Met-Val

C19H29N3O5S (411.1828)

Tyr-Thr-Glu

C18H25N3O8 (411.1642)

Val-Met-Tyr

C19H29N3O5S (411.1828)

Asp-Met-Phe

C18H25N3O6S (411.1464)

Val-Tyr-Met

C19H29N3O5S (411.1828)

Phe-Asp-Met

C18H25N3O6S (411.1464)

Gln-Gln-His

C16H25N7O6 (411.1866)

Gln-His-Gln

C16H25N7O6 (411.1866)

His-Gln-Gln

C16H25N7O6 (411.1866)

Met-Tyr-Val

C19H29N3O5S (411.1828)

Phe-Met-Asp

C18H25N3O6S (411.1464)

Tyr-Val-Met

C19H29N3O5S (411.1828)

alpha-L-Rhap-(1->3)-beta-D-GlcpO[CH2]5NH2

C17H33NO10 (411.2104)

N-[(2S)-1-oxo-1-[[(2S)-1-oxo-1-[2-(2,4,5-trihydroxyphenyl)ethylamino]propan-2-yl]amino]propan-2-yl]carbamic acid tert-butyl ester

C19H29N3O7 (411.2005)

Lnape 9:0/N-3:0

C17H34NO8P (411.2022)

Lnape 6:0/N-6:0

C17H34NO8P (411.2022)

Lnape 3:0/N-9:0

C17H34NO8P (411.2022)

Lnape 7:0/N-5:0

C17H34NO8P (411.2022)

Lnape 5:0/N-7:0

C17H34NO8P (411.2022)

Lnape 4:0/N-8:0

C17H34NO8P (411.2022)

Lnape 8:0/N-4:0

C17H34NO8P (411.2022)

Lnape 2:0/N-10:0

C17H34NO8P (411.2022)

Lnape 10:0/N-2:0

C17H34NO8P (411.2022)

2-(4-(4-Methoxyphenyl)-6-phenyl-2-pyrimidinylamino)benzoic acid methyl ester

C25H21N3O3 (411.1583)

2,4-Dibenzyl-4,4A-dihydro-1H-(1,3,5)triazino(1,2-A)quinoline-1,3,6(2H,5H)-trione

C25H21N3O3 (411.1583)

(3-Acetyloxy-2-heptanoyloxypropyl) 2-(trimethylazaniumyl)ethyl phosphate

C17H34NO8P (411.2022)

(2-Hexanoyloxy-3-propanoyloxypropyl) 2-(trimethylazaniumyl)ethyl phosphate

C17H34NO8P (411.2022)

[1-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-3-pentanoyloxypropan-2-yl] heptanoate

C17H34NO8P (411.2022)

[1-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-3-butanoyloxypropan-2-yl] octanoate

C17H34NO8P (411.2022)

[1-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-3-propanoyloxypropan-2-yl] nonanoate

C17H34NO8P (411.2022)

(3-Butanoyloxy-2-pentanoyloxypropyl) 2-(trimethylazaniumyl)ethyl phosphate

C17H34NO8P (411.2022)

[1-Acetyloxy-3-[2-aminoethoxy(hydroxy)phosphoryl]oxypropan-2-yl] decanoate

C17H34NO8P (411.2022)

1-(10-{2-[4-(2-hydroxyethyl)piperazin-1-yl]ethyl}-10H-phenothiazin-2-yl)propan-1-one

C23H29N3O2S (411.198)

1,2-dihexanoyl-sn-glycero-3-phosphoethanolamine

C17H34NO8P (411.2022)

N-[(9-beta-D-ribofuranosylpurin-6-yl)carbamoyl]threonate

C15H19N6O8 (411.1264)

A hydroxy monocarboxylic acid anion that is the conjugate base of N-[(9-beta-D-ribofuranosylpurin-6-yl)carbamoyl]threonine, obtained by deprotonation of the carboxy group; major species at pH 7.3.

19-O-acetylhoerhammericine(1+)

C23H27N2O5 (411.192)

An ammonium ion derivative resulting from the protonation of the tertiary amino group of 19-O-acetylhoerhammericine. The major species at pH 7.3. Note the stereoconfiguration of the epoxy group is based on CHEBI:144374, and of the 19-acetoxy group on CHEBI:144372.

17alpha-hydroxypregnenolone 3-sulfate(1-)

C21H31O6S (411.1841)

A steroid sulfate oxoanion obtained by deprotonation of the sulfo group of 17alpha-hydroxypregnenolone 3-sulfate.

LPC 7:3;O3

C15H26NO10P (411.1294)

LPC 8:2;O2

C16H30NO9P (411.1658)

LPC 9:1;O

C17H34NO8P (411.2022)

PE 10:0/2:0

C17H34NO8P (411.2022)

Glu-Thr-Tyr

C18H25N3O8 (411.1642)

Met-Met-Met

C15H29N3O4S3 (411.132)

ST 18:2;O6;Gly

C20H29NO8 (411.1893)

ST 22:6;O3;Gly

C24H29NO5 (411.2046)

ST 18:3;O3;Tau

C20H29NO6S (411.1715)

ST 19:2;O2;Tau

C21H33NO5S (411.2079)

E-3620

C20H27Cl2N3O2 (411.148)

E-3620 is a potent 5-HT3 receptor antagonist. E-3620 can be used for the research of dyskinesi and gastrointestinal motility[1][2].

GR 55562 (hydrochloride)

C23H26ClN3O2 (411.1713)

GR 55562 hydrochloride is a selective 5-HT1B receptor antagonist. GR 55562 hydrochloride can be used for the research of nerve disease[1].

MK-6884

C25H25N5O (411.2059)

MK-6884 is a M4 muscarinic receptor positive allosteric modulator (PAM) with a Ki value of 0.19 nM. MK-6884 can be used for the research of the neurodegenerative diseases. MK-6884 can be conveniently radiolabeled with carbon-11 and as a positron emission tomography (PET) imaging agent[1].